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Volume 60, Number 3 Abstracts 8132.1% (86) pharmacologic alone, and 13.7% (569) no prophylaxis. The inci-
dence of VTE in the high-risk group was 1.3% (54) compared with 0.9%
(88) and 0.2% (16) in the medium-risk and low-risk groups, respectively.
Of the 54 high-risk patients who developed VTE, 48 (88%) received appro-
priate prophylaxis as assigned by the risk-assessment model. The incidence
of VTE in the high-risk group was greater when mechanical and pharmaco-
logic prophylaxis were both used (50.0%) compared with pharmacologic
alone (3.7%), mechanical alone (35.2%), or no prophylaxis (11.1%; P ¼
.05; Fig).
Conclusions: Hospital-acquired VTE develops in high-risk patients
despite appropriate risk assessment, identiﬁcation, and prophylaxis with
pharmacologic and mechanical methods. Further consideration for more
aggressive prophylaxis should be given to this high-risk patient population
for VTE prevention.Fig. Incidence of venous thromboembolism (VTE) in all patients based on
prophylaxis.
Table. Comparison of patients treated with endovascular
revascularization (ER) and patients treated with open revascularization
(OR)
Variable ER OR P
Age, mean years 73 6 8 64 6 11 .0003
Comorbidities, % 62 38 .0026
Vessels treated 1.23 6 0.42 1.59 6 0.5 .0032
Restenosis, % 25 4 .029
Hospital LOS, days 5 6 6 13 6 10 .012
Mortality, % 4.8 4 .868
LOS, Length of stay.Disclosures: A. C. Ring: Nothing to disclose; F. Aziz: Nothing to disclose;
M. J. Beck: Nothing to disclose; A. B. Reed: Nothing to disclose
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Objectives: Wound complications (WCs), such as surgical site infec-
tion, wound dehiscence, hematoma, and seroma after surgery cause signif-
icant morbidity and require additional resources to treat. We sought to
quantify the marginal cost of WCs in patients undergoing open lower ex-
tremity vascular procedures.
Methods: Hospital administrative accounting cost data from a single
tertiary institution were analyzed in patients enrolled in a prospective,
randomized trial testing two postoperative wound dressings (gauze vs silver-
coated alginate). A Wilcoxon rank sum test was used to assess the incremen-
tal cost of WCs at 30 days.
Results: Of the 224 patients who underwent lower extremity
vascular surgery procedures, 61 (27.2%) developed WC, 40 (17.9%) of
which were a surgical site infection. The mean incremental cost of
WCs was $11,973, reﬂecting a 35% higher cost than non-WC patients
(P ¼ .0112). Patients with WCs had a longer mean index length of
stay (8.2 vs 6.0 days, P ¼ .0025), a higher rate of 30-day readmissions
(23% vs 6%, P ¼ .0001), and a greater mean cumulative 30-day length
of stay (10.1 vs 6.2 days, P ¼ .0001). The tested dressings showed no
efﬁcacy or cost differences.
Conclusions: WCs remain a frequent sequela of open lower extremity
vascular surgery, with signiﬁcant cost and resource utilization. Although the
tested dressing did not demonstrate efﬁcacy in reducing WCs, there remains
potential cost savings for new and effective products or patient care quality
improvements to capture.
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Objectives: Outcomes of open (OR) and endovascular revasculariza-
tion (ER) for chronic mesenteric ischemia (CMI) were analyzed to identify
predictors of endovascular failure.
Methods: Amulticenter, retrospective studywasperformedof all consec-
utive patients with CMI (151 patients/254 vessels) treated from2008 to 2012.
Demographics, comorbidities, etiology, and treatment modalities were
compared. Outcomes included technical success, restenosis requiring reinter-
vention, complications, mortality, and hospital length of stay (LOS).
Results: A total of 126 patients were treated with ER (83%) and 25 pa-
tients with OR (17%). Average follow-up period was 15.5 months. Overall
mortality was 4.6% (7 of 151). A comparison between the two groups is re-
ported in the Table. Among patients treated with ER, 14.3% developed tech-
nical and perfusion-related complications vs 20% in the OR group (P¼ .464).
A subgroup analysis showed patients with ER requiring reinterventions had a
higher incidence of long lesions>2 cm on angiography (55% vs 7%, P< .05).
Patients crossing over from ER to OR had a signiﬁcantly higher mortality
comparedwithERgroup-only (17.6% [3of 17] vs 2.5% [3of 119]),P¼ .007).
Conclusions: ER has similar mortality and shorter hospitalization but
higher rate of restenosis requiring reintervention compared with OR. Pa-
tients with ER who require reintervention appear to have longer lesions
on angiography. Patients who crossed over from ER had a higher mortality
than primary OR or ER patients. These ﬁndings may guide treatment selec-
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Objectives: Recent initiatives have created incentives to reduce length
of stay (LOS) and decrease readmission rates. We sought to elucidate the
risk factors for both outcomes and to clarify the relationship between
them in patients undergoing lower extremity bypass (LEB).
Methods: Peripheral arterial disease patients (PAD) who underwent
LEB were identiﬁed from the 2007 to 2010 California State Inpatient Data-
base. Logarithmically transformed LOS and risk factors were analyzed using
linear regression. Risk factors for 30-day readmission were analyzed using
logistic regression.
Results: Of 6558 patients who underwent LEB, 1541(24%) were
readmitted. The average index LOS was 8.3 days for those who wereyNew England Society for Vascular Surgery
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